LOSE WEIGHT WITH MEDICAL SUPPORT — BUILT FOR MEN
- Your personalised programme is built around medical care, not willpower.
- No generic diets. No guesswork.
- Just science-backed results and expert support.
Find out if you’re eligible
Victoza (liraglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist prescribed to improve blood sugar control in adults and children aged 10 years and above with type 2 diabetes mellitus. Whilst effective for glycaemic management, Victoza commonly causes gastrointestinal side effects, with diarrhoea being one of the most frequently reported. Understanding why this occurs, how common it is, and what can be done to manage it is essential for patients starting or continuing treatment. This article explores the mechanisms behind Victoza-related diarrhoea, its prevalence, practical management strategies, and when to seek medical advice to ensure safe and effective diabetes care.
Quick Answer: Victoza causes diarrhoea primarily through its action on GLP-1 receptors in the gastrointestinal tract, which slows gastric emptying and may alter gut motility and fluid absorption.
Victoza (liraglutide) is a prescription medicine used to improve blood sugar control in adults and children aged 10 years and above with type 2 diabetes mellitus. It belongs to a class of medications called glucagon-like peptide-1 (GLP-1) receptor agonists, which work by mimicking the action of a naturally occurring hormone in the body.
The mechanism of action of Victoza involves several key processes. When administered as a once-daily subcutaneous injection, liraglutide binds to GLP-1 receptors found throughout the body, including in the pancreas and gastrointestinal tract. This binding stimulates insulin secretion from pancreatic beta cells in a glucose-dependent manner, meaning insulin is released only when blood sugar levels are elevated. Simultaneously, Victoza suppresses the release of glucagon, a hormone that raises blood glucose levels, thereby helping to prevent excessive sugar production by the liver.
Beyond its effects on insulin and glucagon, Victoza also slows gastric emptying—the rate at which food leaves the stomach and enters the small intestine. This delayed emptying contributes to improved post-meal blood sugar control and promotes a feeling of fullness, which may contribute to the weight effects seen with treatment (though Victoza is not licensed specifically for weight loss).
Victoza is typically prescribed alongside diet and exercise modifications, and may be used alone or in combination with other diabetes medications such as metformin or sulphonylureas. It should not be used in combination with DPP-4 inhibitors. According to the NICE guideline NG28 for type 2 diabetes management, GLP-1 receptor agonists are valuable treatment options, particularly in patients who require additional glycaemic control or where weight management would be beneficial.
The recommended starting dose is 0.6 mg once daily for at least one week. This initial dose is intended for tolerability and is not effective for glycaemic control. After at least one week, the dose should be increased to 1.2 mg once daily. Based on clinical response, the dose can be further increased to 1.8 mg once daily after at least another week to improve glycaemic control.
Understanding how Victoza interacts with the gastrointestinal system is essential to comprehending why certain side effects, including diarrhoea, may occur during treatment.
LOSE WEIGHT WITH MEDICAL SUPPORT — BUILT FOR MEN
Find out if you’re eligible
Diarrhoea is one of the most frequently reported gastrointestinal side effects associated with Victoza treatment. Clinical trial data and post-marketing surveillance indicate that gastrointestinal adverse effects are particularly common during the initial weeks of therapy, though their intensity typically diminishes over time as the body adjusts to the medication.
According to the Summary of Product Characteristics approved by the MHRA, diarrhoea and nausea are classified as 'very common' adverse reactions (affecting more than 1 in 10 people). Other gastrointestinal effects such as vomiting, dyspepsia, constipation and abdominal pain are generally classified as 'common' (affecting between 1 in 10 and 1 in 100 people). Nausea is typically the most prevalent side effect, particularly during the first weeks of treatment.
The underlying reason Victoza causes diarrhoea is thought to relate to its mechanism of action on the gastrointestinal tract, though the precise mechanism is not fully established. As a GLP-1 receptor agonist, liraglutide slows gastric emptying and may alter gut motility patterns. These changes can potentially affect the normal transit time of intestinal contents and fluid absorption in the colon. Additionally, GLP-1 receptors are present throughout the gastrointestinal system, and their activation may influence secretory processes and intestinal smooth muscle function, potentially leading to looser or more frequent stools.
Several factors may influence an individual's likelihood of experiencing diarrhoea with Victoza:
Dose titration: Starting at 0.6 mg daily for at least one week before increasing to 1.2 mg can help reduce gastrointestinal side effects
Individual sensitivity: Some patients have heightened sensitivity to GLP-1 receptor activation
Concurrent medications: Other diabetes medications, particularly metformin, can compound gastrointestinal effects
Dietary factors: Certain foods may exacerbate symptoms in some individuals
Most patients find that diarrhoea improves significantly within the first few weeks of starting treatment or after dose adjustments, as the gastrointestinal system adapts to the medication's effects. However, the time course varies between individuals, with some experiencing improvement within days while others may take several weeks.
If you experience diarrhoea whilst taking Victoza, several practical strategies can help manage this side effect whilst maintaining effective diabetes control. It is important not to discontinue your medication without consulting your GP or diabetes specialist, as abrupt cessation may compromise your blood sugar management.
Dietary modifications can play a significant role in reducing gastrointestinal symptoms:
Consider adjusting your diet: Some patients find limiting fatty, spicy, or heavily processed foods may help
Reduce fibre temporarily: While fibre is generally beneficial, reducing intake during the adjustment period may help manage symptoms
Eat smaller, more frequent meals: This approach can ease the burden on your digestive system
Stay well hydrated: Diarrhoea increases fluid loss, so drink plenty of water throughout the day to prevent dehydration
Limit caffeine and alcohol: Both substances can stimulate bowel movements and worsen diarrhoea
Timing and administration considerations may also help. Victoza can be injected at any time of day, independent of meals. Taking Victoza at a consistent time each day is important for maintaining blood glucose control. The medication should be administered according to the prescribed titration schedule: starting at 0.6 mg daily for at least one week (for tolerability), then increasing to 1.2 mg daily, with a possible further increase to 1.8 mg daily after at least another week if needed for glycaemic control.
Regarding over-the-counter remedies, anti-diarrhoeal medications such as loperamide may provide temporary relief for mild to moderate symptoms without red flag symptoms. However, you should consult your pharmacist or GP before using these products, as they may not be appropriate for all patients and should only be used short-term. Oral rehydration solutions can help replace lost electrolytes if diarrhoea is persistent.
Monitoring and documentation of your symptoms can be valuable. Keep a diary noting the frequency, severity, and timing of diarrhoea episodes, along with any dietary or lifestyle factors that seem to influence symptoms. This information will be helpful if you need to discuss dose adjustments or alternative treatments with your healthcare team.
Sick-day rules are important if you experience persistent diarrhoea. If you're unable to maintain adequate fluid intake or have persistent diarrhoea, contact your healthcare provider. You may need to temporarily pause certain medications like metformin or SGLT2 inhibitors to reduce dehydration risks. If you take insulin or sulphonylureas, more frequent blood glucose monitoring is advisable as there's an increased risk of hypoglycaemia during illness, especially with reduced food intake.
While mild diarrhoea is a recognised side effect of Victoza that often resolves with time, certain symptoms warrant prompt medical attention. Understanding when to contact your GP or seek urgent care is essential for your safety whilst taking this medication.
Contact your GP or diabetes specialist if you experience:
Persistent diarrhoea lasting more than 7 days despite dietary modifications and adequate hydration
Severe diarrhoea with more than six loose stools per day, particularly if accompanied by cramping or urgency
Signs of dehydration, including dark urine, dizziness, excessive thirst, dry mouth, reduced urination, or feeling lightheaded when standing
Blood or mucus in stools, which could indicate a more serious gastrointestinal condition
Unexplained weight loss beyond what would be expected from improved diabetes control
Abdominal pain that is concerning or persistent
Inability to maintain adequate nutrition or hydration due to gastrointestinal symptoms
Hypoglycaemia (if also taking insulin or sulphonylureas) during periods of reduced food intake due to illness
Seek immediate medical attention (call 999, NHS 111, or attend A&E) if you develop:
Severe, persistent abdominal pain, particularly if radiating to the back or accompanied by vomiting, as this could indicate pancreatitis—a rare but serious potential complication. Stop taking Victoza immediately if pancreatitis is suspected and seek urgent medical review
Signs of severe dehydration including confusion, rapid heartbeat, very low urine output, or fainting
Symptoms of an allergic reaction, such as difficulty breathing, facial swelling, or widespread rash
It is also important to maintain regular contact with your diabetes care team for routine monitoring. Your healthcare provider should assess your response to Victoza, including both its effectiveness in controlling blood sugar and the tolerability of any side effects. Blood tests to monitor kidney function may be recommended, as dehydration from persistent diarrhoea can potentially affect renal function, particularly in patients with pre-existing kidney disease.
If gastrointestinal side effects remain intolerable despite management strategies, your doctor may consider alternative treatment options. These might include switching to a different GLP-1 receptor agonist with a potentially different side effect profile, adjusting the dose, or exploring other classes of diabetes medications that may be better suited to your individual circumstances. Never adjust your Victoza dose or discontinue treatment without medical guidance, as this could compromise your diabetes control and overall health.
You can report any suspected side effects to the MHRA through the Yellow Card Scheme at yellowcard.mhra.gov.uk or via the Yellow Card app.
Most patients find that diarrhoea improves significantly within the first few weeks of starting Victoza or after dose adjustments, as the gastrointestinal system adapts to the medication. The time course varies between individuals, with some experiencing improvement within days whilst others may take several weeks.
Anti-diarrhoeal medications such as loperamide may provide temporary relief for mild to moderate symptoms without red flag features. However, you should consult your pharmacist or GP before using these products, as they may not be appropriate for all patients and should only be used short-term.
Contact your GP or diabetes specialist if diarrhoea persists for more than 7 days, is severe (more than six loose stools daily), or is accompanied by signs of dehydration, blood in stools, severe abdominal pain, or inability to maintain adequate nutrition or hydration.
All medical content on this blog is created based on reputable, evidence-based sources and reviewed regularly for accuracy and relevance. While we strive to keep content up to date with the latest research and clinical guidelines, it is intended for general informational purposes only.
DisclaimerThis content is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional with any medical questions or concerns. Use of the information is at your own risk, and we are not responsible for any consequences resulting from its use.
